Fate Therapeutics Inc. buy Barclays PLC
Start price
27.02.24
/
50%
€6.42
Target price
27.02.25
€9.22
Performance (%)
-81.86%
End price
28.02.25
€1.16
Summary
This prediction ended on 28.02.25 with a price of €1.16. Massive losses of -81.86% were the result for the BUY prediction by Barclays_PLC. Barclays_PLC has a follow-up prediction for Fate Therapeutics Inc. where he still thinks Fate Therapeutics Inc. is a Buy. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Fate Therapeutics Inc. | 1.276% | 1.276% | -51.618% |
| iShares Core DAX® | 0.869% | 3.389% | 22.351% |
| iShares Nasdaq 100 | -0.852% | -2.157% | 5.543% |
| iShares Nikkei 225® | 0.436% | 1.060% | 13.273% |
| iShares S&P 500 | -0.122% | -0.270% | 3.350% |
Comments by Barclays_PLC for this prediction
In the thread Fate Therapeutics Inc. diskutieren
Fate Therapeutics, Inc. (NASDAQ: FATE) had its price target raised by analysts at Barclays PLC from $6.00 to $10.00. They now have an "overweight" rating on the stock.
Ratings data for FATE provided by MarketBeat
In the thread Trading Fate Therapeutics Inc.
Die von Barclays_PLC gewählte maximale Laufzeit wurde überschritten
Current prediction by Barclays_PLC for Fate Therapeutics Inc.
Fate Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.86
14.05.25
14.05.25
€1.79
14.05.26
14.05.26
-2.41%
02.01.26
02.01.26
